A recent legal analysis by CMS examines how updated legislation is reshaping interactions across Ukraine’s pharmaceutical supply chain, introducing clearer boundaries for pharmacy marketing services, post-sale price adjustments, and non-advertising promotion. The overview highlights new reporting obligations, spending caps, and Good Promotional Practice requirements that bring Ukrainian rules closer to EU compliance standards, with significant implications for manufacturers, importers, and retail pharmacies in 2026.